Browse
Submit Data
Databases
API
Help

Dataset Information

7 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

?-1,2-Di-4-pyridylethane-?N:N'-bis-[bis-(N,N-diisopropyl-dithio-carbamato-?S,S')zinc(II)].

ABSTRACT: In the dinuclear title compound, [Zn{S(2)CN(n-Pr)(2)}(2){(NC(5)H(4))CH(2)CH(2)(C(5)H(4)N)}] or [Zn(2)(C(7)H(14)NS(2))(4)(C(12)H(12)N(2))], each Zn atom adopts a distorted trigonal-bipyramidal ZnNS(4) geometry. The crystal structure involves intermolecular C-H?S hydrogen bonds.

SUBMITTER: Avila V

PROVIDER: S-EPMC2961305 | biostudies-other | 2008

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

μ-1,2-Di-4-pyridylethane-κN:N'-bis-[bis-(N,N-diisopropyl-dithio-carbamato-κS,S')zinc(II)].

Avila Vanessa V Tiekink Edward R T ER

Acta crystallographica. Section E, Structure reports online 20080418 Pt 5

In the dinuclear title compound, [Zn{S(2)CN(n-Pr)(2)}(2){(NC(5)H(4))CH(2)CH(2)(C(5)H(4)N)}] or [Zn(2)(C(7)H(14)NS(2))(4)(C(12)H(12)N(2))], each Zn atom adopts a distorted trigonal-bipyramidal ZnNS(4) geometry. The crystal structure involves intermolecular C-H⋯S hydrogen bonds. ...[more]

PMID: 21202218

Similar Datasets

(?-trans-1,2-Di-4-pyridylethyl-ene-?N:N')bis-[bis-(N,N-diisopropyl-dithio-carbamato-?S,S')zinc(II)].

Project description:The dinuclear title compound, [Zn(2)(C(7)H(14)NS(2))(4)(C(12)H(10)N(2))], is centrosymmetric about the central C=C bond. The five-coordinate Zn atom is bonded to two asymmetrically chelating dithio-carbamate ligands and a pyridine N atom to define an NS(4) coordination geometry tending towards a square pyramid, with the N atom in the apical site. In the crystal structure, C-H?S contacts lead to supra-molecular chains.

| S-EPMC2971214 | biostudies-other

(?-1,2-Di-4-pyridylethyl-ene-?N:N')bis-[bis-(N,N-dimethyl-dithio-carbamato-?S,S')zinc(II)].

Project description:The dinuclear title compound, [Zn(2)(C(3)H(6)NS(2))(4)(C(12)H(10)N(2))], features two five-coordinate Zn atoms, one with an NS(4) coordination geometry distorted towards a trigonal-bipyramidal arrangement, and the other distorted towards a square pyramid. In the crystal, mol-ecules are connected into supra-molecular zigzag chains via C-H?S contacts. Chains are connected via C-H?? interactions, consolidating the crystal packing.

| S-EPMC2971210 | biostudies-other

Bis(N-isobutyl-N-propyl-dithio-carbamato-?S,S')zinc(II).

Project description:In the title compound, [Zn(C(8)H(16)NS(2))(2)], the Zn(II) atom is chelated by two S,S'-bidentate dithio-carbamate ions in a very distorted tetra-hedral geometry. The alkyl chains of the ligands are equally disordered over two sets of sites.

| S-EPMC2979964 | biostudies-literature

Bis(?-N-benzyl-N-tetra-decyl-dithio-carbamato-?S:S')bis-[(N-benzyl-N-tetra-decyl-dithio-carbamato-?S,S')zinc(II)].

Project description:In the title compound, [Zn(2)(C(22)H(36)NS(2))(4)], two bidentate dithio-carbamate groups chelate directly to the Zn(II) atoms, whereas the two remaining dithio-carbamate ligands bridge the Zn atoms via a crystallographic inversion centre. The Zn atoms show a strongly distorted tetra-hedral geometry. Adding the long S?S distance with the inversion centre being in the middle, the resulting five-coordinate geometry around the Zn atoms can be considered to be between distorted recta-ngular pyramidal and trigonal bipyramidal, with a calculated ? value of 0.31. In this dimer complex, two inversion-related tetra-decyl carbon chains exhibit all-trans conformations, and the other two chains show a cis conformation at the end of the chains.

| S-EPMC2969063 | biostudies-literature

(?-4,4'-Bipyridine-?N:N')bis-[bis-(N,N-dimethyl-dithio-carbamato-?S,S')zinc(II)].

Project description:The title dinuclear Zn(II) complex, [Zn(2)(C(3)H(6)NS(2))(4)(C(10)H(8)N(2))], is centrosymmetric; the mid-point of the C-C bond linking the two pyridine rings is located on an inversion center. The pyridine N atom coordinates to the Zn(II) cation, which is also chelated by two dimethyl-dithio-carbamate anions, giving a trigonal-bipyramidal ZnNS(4) geometry. Weak inter-molecular C-H?S hydrogen bonding is present in the crystal structure.

| S-EPMC3009053 | biostudies-literature

(?-trans-1,2-Di-4-pyridylethyl-ene-?N:N')bis-[bis-(N,N-diethyl-dithio-carbamato-?S,S')zinc(II)] chloro-form solvate.

Project description:The dinuclear title solvate, [Zn(2)(C(5)H(10)NS(2))(4)(C(12)H(10)N(2))]·CHCl(3), features two five-coordinate Zn atoms; both coordination polyhedra are distorted, but one has an NS(4) donor set approximating to a square pyramid (with the N atom in the apical site), while the other is closer to a ZnNS(4) trigonal-bipyramidal arrangement (with the N atom in an equatorial site). In both cases, the Zn(II) atom is chelated by two S,S'-bidentate dithiol-ate ligands. In the crystal, the chloro-form solvent mol-ecules reside in cavities defined by the dinuclear species and are held in place via C-H?S contacts.

| S-EPMC2971174 | biostudies-other

Bis(?-N,N-di-allyl-dithio-carbamato)bis[(N,N-di-allyl-dithio-carbamato)cadmium].

Project description:The title compound, [Cd2(C7H10NS2)4], is a neutral dinuclear cadmium(II) complex bearing four bis N,N-di-allyl-di-thio-carbamate ligands coordinating to two CdII cations. In each of the monomeric subunits, there are four S atoms of two di-thio-carbamate ligands [Cd-S = 2.5558?(3), 2.8016?(3), 2.6050?(3) and 2.5709?(3)?Å] that coordinate to one CdII atom in a bidentate mode. The dimers are located over an inversion centre bridged by two additional bridging Cd-S bonds [2.6021?(3)?Å], leading to a substantial distortion of the geometry of the monomeric subunit from the expected square-planar geometry. The five-coordinate environment around each of the CdII ions in the dimer is best described as substanti-ally tetra-gonally distorted square pyramidal. The di-thio-carbamate groups are themselves planar and are also coplanar with the CdII ions. The negative charge on these groups is delocalized by resonance across the S atoms bound to the CdII cation. This delocalization of the ? electrons in the di-thio-carbamate groups also extends to the C-N bonds as they reveal significant double bond character [C-N = 1.3213?(16) and 1.3333?(15)?Å].

| S-EPMC5588579 | biostudies-literature

Bis(?-N,N-dimethyl-dithio-carbamato-?S,S':S)bis-[(N,N-dimethyl-dithio-carbamato-?S,S')copper(II)].

Project description:In the centrosymmetric dimeric title compound, [Cu(2)(C(3)H(6)NS(2))(4)], the Cu(II) atom is five-coordinate in a square-pyramidal environment. The basal coordination positions are occupied by four S atoms from two dimethyl-dithio-carbamate ligands and the apical coordination position is occupied by an S atom also bonded to the other Cu atom.

| S-EPMC2968622 | biostudies-literature

(2,2'-Bipyridine-κN,N')bis-(N-ethyl-N-methyl-dithio-carbamato-κS,S')zinc(II).

Project description:The complete mol-ecule of the title compound, [Zn(C(4)H(8)NS(2))(2)(C(10)H(8)N(2))], is generated by crystallographic twofold symmetry, with the Zn atom lying on the rotation axis; the axis also bis-ects the central C-C bond of the 2,2'-bipyridine mol-ecule. The metal atom is chelated by two S,S'-bidentate dithio-carbamate anions and the N,N'-bidentate heterocycle, resulting in a distorted cis-ZnN(2)S(4) octa-hedral geometry. The methyl and ethyl groups of the anion are statistically disordered.

| S-EPMC2979959 | biostudies-literature

Bis(N-sec-butyl-N-n-propyl-dithio-carbamato-?S,S')(1,10-phenanthroline-?N,N')zinc(II).

Project description:Two independent but very similar mol-ecules comprise the asymmetric unit of the title compound, [Zn(C(8)H(16)NS(2))(2)(C(12)H(8)N(2))]. The N(2)S(4) donor set about Zn is defined by two symmetrically chelating dithio-carbamate ligands and a 1,10-phenanthroline ligand. Distortions from the ideal octa-hedral coordination geometry arise from the restricted bite angles of the ligands. The main feature of the crystal packing is the formation of tetra-meric supra-molecular aggregates mediated by C-H?S inter-actions. Disorder was found in each of the sec-butyl groups. This was resolved over two positions in each case with the major components of the disorder having site occupancies in the range 0.551?(6)-0.725?(5).

| S-EPMC3008025 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data